Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Substitution of calcineurin inhibitors with corticosteroids after allogeneic hematopoietic cell transplantation.
Matsumi S, Kimura SI, Nakamura Y, Kawamura M, Takeshita J, Kawamura S, Yoshino N, Misaki Y, Yoshimura K, Gomyo A, Okada Y, Akahoshi Y, Tamaki M, Kusuda M, Kameda K, Wada H, Tanihara A, Sato M, Nakasone H, Kako S, Kanda Y. Matsumi S, et al. Among authors: kimura si. Int J Hematol. 2023 Oct;118(4):450-461. doi: 10.1007/s12185-023-03645-4. Epub 2023 Jul 22. Int J Hematol. 2023. PMID: 37480446
Cell-Free and Concentrated Ascites Reinfusion Therapy during Hemodialysis for Intradialytic Hypotension and Intractable Ascites.
Hayasaka H, Ito K, Ookawara S, Kofuji M, Uchida T, Kawamura S, Gomyo A, Miyazawa H, Ueda Y, Hirai K, Kimura SI, Momose N, Kako S, Morishita Y. Hayasaka H, et al. Among authors: kimura si. Case Rep Nephrol. 2022 Oct 15;2022:7099227. doi: 10.1155/2022/7099227. eCollection 2022. Case Rep Nephrol. 2022. PMID: 36284565 Free PMC article.
Very early death within 30 days after diagnosis in patients with acute myeloid leukemia.
Kusuda M, Nakasone H, Nakamura Y, Kawamura M, Takeshita J, Kawamura S, Yoshino N, Misaki Y, Yoshimura K, Matsumi S, Gomyo A, Tanihara A, Tamaki M, Kameda K, Kimura SI, Kako S, Kanda Y. Kusuda M, et al. Among authors: kimura si. Int J Hematol. 2023 Feb;117(2):198-205. doi: 10.1007/s12185-022-03482-x. Epub 2022 Nov 1. Int J Hematol. 2023. PMID: 36316607
Chronic active Epstein-Bar virus infection complicated by pulmonary artery hypertension.
Misaki Y, Minakata D, Ibe T, Gomyo A, Yoshimura K, Kimura SI, Nakamura Y, Kawamura M, Kawamura S, Takeshita J, Yoshino N, Matsumi S, Akahoshi Y, Tamaki M, Kusuda M, Kameda K, Wada H, Kawamura K, Sato M, Terasako-Saito K, Tanihara A, Hatano K, Nakasone H, Imadome KI, Wada H, Kako S, Oshiro H, Tanaka A, Kanda Y. Misaki Y, et al. Among authors: kimura si. J Infect Chemother. 2023 Feb;29(2):212-218. doi: 10.1016/j.jiac.2022.10.013. Epub 2022 Oct 28. J Infect Chemother. 2023. PMID: 36374666
Clinical features of febrile neutropenia and bloodstream infection in autologous hematopoietic cell transplantation: Comparison to those in intensive chemotherapy for acute myeloid leukemia.
Yoshino N, Kimura SI, Matsuoka A, Meno T, Ishikawa T, Nakamura Y, Kawamura M, Takeshita J, Kawamura S, Misaki Y, Yoshimura K, Gomyo A, Okada Y, Tamaki M, Akahoshi Y, Kusuda M, Kameda K, Tanihara A, Wada H, Nakasone H, Kako S, Kanda Y. Yoshino N, et al. Among authors: kimura si. J Infect Chemother. 2023 Apr;29(4):384-390. doi: 10.1016/j.jiac.2023.01.004. Epub 2023 Jan 18. J Infect Chemother. 2023. PMID: 36669687
[Anti-MDA5 antibody-positive rapidly progressive interstitial lung disease after allogeneic hematopoietic cell transplantation successfully treated with triple immunosuppressive therapy].
Nakamura Y, Kawamura S, Matsumi S, Matsumoto K, Tanaka S, Ishikawa T, Matsuoka A, Meno T, Kawamura M, Takeshita J, Yoshino N, Yoshimura K, Misaki Y, Gomyo A, Okada Y, Tamaki M, Kusuda M, Akahoshi Y, Kameda K, Wada H, Kimura SI, Nakasone H, Kako S, Date H, Kanda Y. Nakamura Y, et al. Among authors: kimura si. Rinsho Ketsueki. 2023;64(4):250-254. doi: 10.11406/rinketsu.64.250. Rinsho Ketsueki. 2023. PMID: 37121767 Japanese.
Plasma ubiquitin C-terminal hydrolase-L1 (UCH-L1) level as a blood biomarker of neurological damage after allogeneic hematopoietic cell transplantation.
Okada Y, Nakasone H, Yoshimura K, Tamaki M, Kusuda M, Nakamura Y, Kawamura M, Kawamura S, Takeshita J, Yoshino N, Misaki Y, Gomyo A, Tanihara A, Kimura SI, Kako S, Kanda Y. Okada Y, et al. Among authors: kimura si. Int J Hematol. 2023 Sep;118(3):340-346. doi: 10.1007/s12185-023-03642-7. Epub 2023 Jul 22. Int J Hematol. 2023. PMID: 37480445
Treatment strategy at the decision for allogeneic transplantation in patients with myelodysplastic syndrome in the era of azacitidine: A KSGCT prospective study.
Kako S, Kimura SI, Wada H, Komiya Y, Nakasone H, Sakurai M, Kato J, Tanaka M, Fujii E, Tachibana T, Yamamoto W, Hagihara M, Watanabe R, Yokota A, Nakano H, Mori T, Nakaseko C, Kanamori H, Okamoto S, Kanda Y. Kako S, et al. Among authors: kimura si. Leuk Res. 2023 Oct;133:107371. doi: 10.1016/j.leukres.2023.107371. Epub 2023 Aug 7. Leuk Res. 2023. PMID: 37595372
Clinical Impact of Pretransplantation Physical Function on Transplantation after Allogeneic Hematopoietic Cell Transplantation in Older Adults.
Gomyo A, Kimura SI, Suzuki J, Ishikawa T, Meno T, Matsuoka A, Nakamura Y, Kawamura M, Kawamura S, Takeshita J, Yoshino N, Misaki Y, Yoshimura K, Okada Y, Akahoshi Y, Tamaki M, Kusuda M, Kameda K, Wada H, Sato M, Tanihara A, Sekine K, Nakasone H, Kako S, Kanda Y. Gomyo A, et al. Among authors: kimura si. Transplant Cell Ther. 2023 Nov;29(11):721.e1-721.e8. doi: 10.1016/j.jtct.2023.08.023. Epub 2023 Aug 27. Transplant Cell Ther. 2023. PMID: 37643718
193 results